Search

The Bann Laboratory focuses on discovering novel mechanistic targets to treat heart failure. We aim to identify regulators of cardiac cell fate reprogramming and regeneration as a molecular strategy to repair and heal the heart following injury.

The Drapkin Lab investigates the molecular drivers of oncogenesis, metastasis, and chemoresistance in small cell lung cancer (SCLC) to discover new therapeutic targets. 

Research in the Kober lab focuses on understanding how enzymatic functions are regulated. We take highly interdisciplinary approaches and primarily focus on the mechanisms of protein homeostasis in the context of lipid metabolism.

Contact the Malladi Lab

Skip to main content Mission and Values Our Mission To address research topics that are both intellectually intriguing and medically relevant by employing mechanistic, hypothesis-driven approaches using innovative technologies. To disseminate our research findings and reagents to the broader scientif…

Skip to main content Publications Featured Publications AXL/WRNIP1 mediates replication stress response and promotes therapy resistance and metachronous metastasis in HER2+ breast cancer. Marquez-Palencia M, Reza Herrera L, Parida PK, Ghosh S, Kim K, Das NM, Gonzalez-Ericsson PI, Sanders ME, Mobley B…

Summary of previous research according to topics

Malladi Lab photo gallery.

The Bann Laboratory focuses on discovering novel mechanistic targets to treat heart failure. We aim to identify regulators of cardiac cell fate reprogramming and regeneration as a molecular strategy to repair and heal the heart following injury.

Skip to main content Health Care Delivery Research Efficient delivery of proven health care interventions plays a critical role in outcomes for patients at-risk and with HCC. We have shown that delays in diagnosis and treatment, fragmentation of care, and disparities in access can significantly impac…